This study is testing a new way to remove glioblastoma, a type of brain cancer, during surgery. It uses a special type of MRI called amine chemical exchange saturation transfer pH weighted MRI before surgery. This MRI helps doctors find areas of the tumor that are harder to see, including those that have spread beyond the main tumor. During surgery, this information will guide doctors to remove more of the tumor. The main goal is to see if this new surgical approach causes any serious side effects within two months. This study is looking for 18 participants who are at least 18 years old and have newly diagnosed or recurring glioblastoma.

Study design

This is a single-center, single-arm study, meaning all participants will receive the same intervention. It aims to enroll 18 participants.

What's involved

You would undergo standard pre-operative medical checks and MRIs, including a special CEST-EPI MRI. The study involves surgery to remove the tumor, guided by the special MRI.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint for measuring side effects is at 2 months. Your total participation in the study will last two years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.